CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
73 hedge funds and large institutions have $122M invested in CASI Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9% more funds holding
Funds holding: 67 → 73 (+6)
0.15% more ownership
Funds ownership: 3.2% → 3.34% (+0.15%)
Holders
73
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.21M | |
| 2 | +$1.41M | |
| 3 | +$889K | |
| 4 |
WSC
Wellington Shields & Co
New York
|
+$724K |
| 5 |
BlackRock
New York
|
+$693K |
Top Sellers
| 1 | -$1.15M | |
| 2 | -$1.11M | |
| 3 | -$591K | |
| 4 |
Goldman Sachs
New York
|
-$320K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$172K |